Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits

Journal of Bone and Mineral Research

Volumn 20, Issue 10, 2005, Pages 1731-1741

  Smith, Elisabeth J ^a,b,c   Little, David G ^b   Briody, Julie N ^b   McEvoy, Anthony ^b   Smith, Nicholas C ^b   Eisman, John A ^a   Gardiner, Edith M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Endochondral cartilage; Nitrogen containing bisphosphonates; Physeal morphology; Rabbit; Tibial length

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; NITROGEN DERIVATIVE; ZOLEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BONE DEVELOPMENT; CARTILAGE MATRIX; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; LEG LENGTHENING; METAPHYSIS; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PERTHES DISEASE; RABBIT;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CARTILAGE; CHILD; CHILD, PRESCHOOL; DIAPHYSES; DIPHOSPHONATES; HUMANS; IMIDAZOLES; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; RABBITS; TIBIA; TIME FACTORS;

EID: 25444502607     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050604     Document Type: Article

References (41)

1. Russell RG, Rogers MJ 1999 Bisphosphonates: From the laboratory to the clinic and back again. Bone 25:97-106.
2. Seeman E 1997 Osteoporosis: Trials and tribulations. Am J Med 103:S74-S89.
3. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH 1990 Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265-1271.
4. Astrom E, Soderhall S 2002 Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356-364.
5. Astrom E, Soderhall S 1998 Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr 87:64-68.
6. Brumsen C, Hamdy NA, Papapoulos SE 1997 Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine 76:266-283.
7. Kauffman RP, Overton TH, Shiflett M, Jennings JC 2001 Osteoporosis in children and adolescent girls: Case report of idiopathic juvenile osteoporosis and review of the literature. Obstet Gynecol Surv 56:492-504.
8. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R 1998 Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947-952.
9. Kim HKW, Randall TS, Bian H, Jenkins J, Garces A, Bauss F 2005 Ibandronate prevents femoral head deformity following ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87:550-558.
10. Little DG, Cornell MS, Briody J, Cowell CT, Arbuckle S, Cooke-Yarborough CM 2001 Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits. J Bone Joint Surg Br 83:1069-1074.
11. Little DG, Smith NC, Williams PR, Broidy JN, Bilston LE, Smith EJ, Gardiner EM, Cowell CT 2003 Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 18:1300-1307.
12. Little DG, McDonald MM, Sharpe IT, Peat RA, Williams PR, McEvoy A 2005 Zoledronic acid improves femoral head sphericity in a rat model of Perthes disease. J Orthop Res (in press).
13. Little DG, Peat RA, McEvoy A, Williams PR, Smith EJ, Baldock PA 2003 Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 18:2016-2022.
14. Smith EJ, McEvoy A, Little DG, Baldock PA, Eisman JA, Gardiner EM 2004 Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis. J Bone Miner Res 19:1698-1705.
15. Larsson A, Larsson S 1978 The effects of ethylene-1-hydroxy-1,1- diphosphonate on cellular transformation and organic matrix of the epiphyseal growth plate of the rat-a light microscopic and ultrastructural study. Acta Pathol Microbiol Scand 86:211-223.
16. Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H 1973 Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196-214.
17. Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, Ilg WA, Toledano TR, Boskey AL 2001 A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 69:94-101.
18. Li J, Mori S, Kaji Y, Kawanishi J, Akiyama T, Norimatsu H 2000 Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J Bone Miner Res 15:2042-2051.
19. Pataki A, Muller K, Green JR, Ma YF, Li QN, Jee WSS 1997 Effects of short-term treatment with the bisphosphonates zoledronic and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249:458-468.
20. Evans KD, Lau ST, Oberbauer AM, Martin RB 2003 Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. Bone 32:268-274.
21. van Persijn van Meerten EL, Kroon HM, Papapoulos SE 1992 Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 184:249-254.
22. Rauch F, Travers R, Munns C, Glorieux FH 2004 Clinical Vignette. Sclerotic metaphyseal lines in a child treated with pamidronate. J Bone Miner Res 19:1191-1193.
23. Masoud I, Shapiro F, Kent R, Moses A 1986 A longitudinal study of the growth of the New Zealand white rabbit: Cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length. J Orthop Res 4:221-231.
24. Alvarez J, Balbin M, Santos F, Fernandez M, Ferrando S, Lopez JM 2000 Different bone growth rates are associated with changes in the expression pattern of types II and X collagens and collagenase 3 in proximal growth plates of the rat tibia. J Bone Miner Res 15:82-94.
25. Cobo A, Lopez JM, Carbajo E, Santos F, Alvarez J, Fernandez M, Weruaga A 1999 Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rates. J Am Soc Nephrol 10:971-979.
26. McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP 2002 Alendronate treatment for infants with osteogenesis imperfecta: Demonstration of efficacy in a mouse model. Pediatr Res 52:660-670.
27. Deckers MML, van Beek ER, van der Pluijm G, Wetterwald A, van der Wee-pals L, Cecchini MG, Papapoulos SE, Lowik CWGM 2002 Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice. J Bone Miner Res 17:998-1007.
28. Porat S, Peyser A, Robin GC 1991 Equalization of lower limbs by epiphysiodesis: Results of treatment. J Pediatr Orthop 11:442-448.
29. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH 2003 Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569-4575.
30. Zeitlin L, Rauch F, Plotkin H, Glorieux FH 2003 Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111:1030-1036.
31. Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M 2003 Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health 39:88-92.
32. Hogler W, Yap F, Little DG, Ambler G, McQuade M, Cowell CT 2004 Short-term safety assessment in the use of zoledronic acid in children. J Pediatr 145:701-704.
33. Hunziker EB, Schenk RK 1989 Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J Physiol 414:55-71.
34. Breur GJ, Turgai J, Vanenkevort BA, Farnum CE, Wilsman NJ 1994 Stereological and serial section analysis of chondrocytic enlargement in the proximal tibial growth-plate of the rat. Anat Rec 239:255-268.
35. Farnum CE, Wilsman NJ 1989 Cellular turnover at the chondro-osseous junction of the growth plate cartilage: Analysis by serial sections at the light microscopical level. J Orthop Res 7:654-666.
36. Lee ER, Lamplugh L, Shepard NL, Mort JS 1995 The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage. J Histochem Cytochem 43:525-536.
37. Schenk RK, Spiro D, Wiener J 1967 Cartilage resorption in the tibial epiphyseal plate of growing rates. J Cell Biol 34:275-291.
38. Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G 2000 Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231-241.
39. Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS 2002 Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 61:925-928.
40. Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL 2003 Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res 9:295-306.
41. Giraudo E, Inoue M, Hanahan D 2004 An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114:623-633.